Universal Health Services (UHS) Financial History
Review Universal Health Services annual and quarterly financial results, key ratios, insider transactions and SEC filing history in one chronological view. Data available from FY2008 through FY2025.
Financials
18 fiscal years, FY2008 to FY2025
Insider trades
471 trades
Risk factor changes
55 changes in the latest 10-K
Filings
Annual and quarterly reports
Compare
Side by side with another company
Universal Health Services Financial Statements
History since FY2008. Annual, in US dollars. Source: 10-K XBRL data.
Universal Health Services Revenue and Growth
Compare reported revenue and year-over-year revenue growth across available fiscal years.
Universal Health Services Income Statements
Review revenue, gross profit, operating income, net income and earnings per share.
Universal Health Services Balance Sheets
Review reported debt and book-value-based ratios where company data is available.
Universal Health Services Cash Flow Statements
Compare reported free cash flow across the available fiscal history.
Universal Health Services Financial Ratios
Compare net margin, price-to-earnings and price-to-book ratios by fiscal year.
| Fiscal year | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY202210 new risk factorsInsiders net sold $242K | FY2023 | FY202418 new risk factorsInsiders net sold $15.6M | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $12.6B | $13.4B | $14.3B | $15.8B | $17.4B |
| Revenue growth | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | — | +6.0% | +6.6% | +10.8% | +9.7% |
| Gross profit | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | — | — | — | — | — |
| Operating income | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $1.4B | $1.0B | $1.2B | $1.7B | $2.0B |
| Net income | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $1.0B | $0.7B | $0.7B | $1.1B | $1.5B |
| Debt | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $4.3B | $4.9B | $5.0B | $4.6B | $4.8B |
| Free cash flow | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $28.0M | $0.3B | $0.5B | $1.1B | $0.8B |
| Net margin | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | 7.8% | 5.0% | 5.0% | 7.2% | 8.6% |
| EPS (diluted) | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $11.82 | $9.14 | $10.23 | $16.82 | $23.10 |
| P/E ratio | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | 11.0× | 15.4× | 14.9× | 10.7× | 9.4× |
| P/B ratio | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | — | — | — | — | — |
Daily closing prices, aggregated by calendar year.
| Year | 2000 🔒 | 2001 🔒 | 2002 🔒 | 2003 🔒 | 2004 🔒 | 2005 🔒 | 2006 🔒 | 2007 🔒 | 2008 🔒 | 2009 🔒 | 2010 🔒 | 2011 🔒 | 2012 🔒 | 2013 🔒 | 2014 🔒 | 2015 🔒 | 2016 🔒 | 2017 🔒 | 2018 🔒 | 2019 🔒 | 2020 🔒 | 2021 🔒 | 2022 | 2023 | 2024 | 2025 | 2026 (YTD) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Open | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $129.53 | $142.30 | $152.02 | $180.65 | $217.01 |
| Close | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $140.88 | $152.42 | $179.44 | $217.92 | $198.74 |
| High | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $158.11 | $158.56 | $242.84 | $246.32 | $243.69 |
| Low | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $82.52 | $113.77 | $150.11 | $152.96 | $140.05 |
| Annual return | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | +8.6% | +8.2% | +17.7% | +21.4% | -8.8% |
Universal Health Services Insider Transactions
From Form 4 filings. Showing the latest 5 of 471 trades.
| Traded | Filed | Insider | Type | Shares | Value | % of holdings |
|---|---|---|---|---|---|---|
| 2026-05-27 | 2026-05-29 | Alan Miller Executive Chairman | Other (20 trades) | 456,116 | — | — |
| 2026-05-20 | 2026-05-21 | Nina Chen-Langenmayr Director | Grant or award (4 trades) | 4,868 | — | — |
| 2026-05-20 | 2026-05-21 | Elliot Md Mba Sussman Director | Grant or award (4 trades) | 4,868 | — | — |
| 2026-05-20 | 2026-05-21 | Eileen McDonnell Director | Grant or award (4 trades) | 4,868 | — | — |
| 2026-05-20 | 2026-05-21 | Maria Ruderman Singer Director | Grant or award (4 trades) | 4,868 | — | — |
Universal Health Services Risk Factor Changes
Latest 10-K compared with the year before. 55 changes found.
In the event a holder of Class C or Class D Common Stock holds a number of shares of Class A or Class B Common Stock, respectively, less than ten times the number of shares of Class C or Class D Common Stock that hold…
As of March 17, 2025, the shares of Class A and Class C Common Stock, which constituted 11.1% of the aggregate outstanding shares of our Common Stock, had the right to elect five members of the Board of Directors and…
In October 2025, our Board of Directors authorized a $1.5 billion increase to our stock repurchase program.
issuance of stock under other incentive plans.
In addition, as of December 31, 2025, we had approximately $4.0 billion of goodwill recorded on our consolidated balance sheet.
Our revenues and volume trends are dependent on many factors, including physicians’ clinical decisions and availability, payer programs shifting to a more outpatient-based environment, whether or not certain services…
As cyber criminals continue to become more sophisticated through evolution of their tactics, techniques and procedures, we have taken, and will continue to take, additional preventive measures to strengthen the cyber…
Changes in laws or policies governing the terms of foreign trade, and in particular increased trade restrictions, tariffs or taxes on imports from where our import products or materials (either directly or through our…
All professional and general liability insurance we purchase is subject to policy limitations.
We are uncertain as to the ultimate financial exposure related to the Cumberland matter (which relate to occurrences in the 2020 policy year) and we can make no assurances regarding timing or substance of their outcom…
For example, as discussed elsewhere herein, Cumberland Hospital for Children and Adolescents (“Cumberland”), an indirect subsidiary of the Company, is a defendant in multi-plaintiff lawsuits filed in the Circuit Court…
Our operations in the United Kingdom are also subject to a high level of regulation relating to registration and licensing requirements employee regulation, clinical standards, environmental rules, data protection as…
Among these laws are the federal False Claims Act, the Health Insurance Portability and Accountability Act of 1996, (“HIPAA”), the federal anti-kickback statute and the provision of the Social Security Act commonly kn…
Under the Legislation, hospitals are required to make public a list of their standard charges, and effective January 1, 2019, CMS has required that this disclosure be in machine-readable format and include charges for…
The Inflation Reduction Act of 2022 (“IRA”) was passed on August 16, 2022, which among other things, allows for CMS to negotiate prices for certain single-source drugs and biologics reimbursed under Medicare Part B an…
The Legislation and its implementation have been, and remain, politically controversial.
A 2012 U.S.
Although it was expected that as a result of the Legislation there would be a reduction in uninsured patients, which would reduce our expense from uncollectible accounts receivable, the Legislation makes a number of o…
Beginning in federal fiscal year 2028, the Medicaid disproportionate share hospital (“DSH”) allotment to the states from federal funds will be reduced.
events.
The economies in the communities in which our hospitals operate are often dependent on a small number of large employers.
The nationwide shortage of nurses and other clinical staff and support personnel has been a significant operating issue facing us and other healthcare providers.
The technology used in medical equipment and related devices is constantly evolving and, as a result, manufacturers and distributors continue to offer new and upgraded products to health care providers.
Typically, physicians are responsible for making hospital admissions decisions and for directing the course of patient treatment.
We expect that government pressure on managed care organizations through static or reduced funding received by these payers from government sources such as through Medicare Advantage plans will in turn increase the pr…
As discussed in Item 7.
unable to predict the effect of future policy changes on our operations.
California: We own 5 inpatient acute care hospitals, 4 acute outpatient centers, 9 inpatient behavioral healthcare facilities and 12 behavioral healthcare outpatient facilities as listed in Item 2.
Nevada: We own 10 inpatient acute care hospitals, 13 free-standing emergency departments, 4 acute outpatient centers and 4 inpatient behavioral healthcare facilities and 1 behavioral outpatient facility as listed in I…
Texas: We own 7 inpatient acute care hospitals, 16 free-standing emergency departments, 2 acute outpatient centers and 20 inpatient behavioral healthcare facilities and 14 behavioral healthcare outpatient facilities a…
In the event a holder of Class C or Class D Common Stock holds a number of shares of Class A or Class B Common Stock, respectively, less than ten times the number of shares of Class C or Class D Common Stock that hold…
Continuing Inflationary Pressures continue to increase our operating costs and we may not be able to pass on increases in costs commensurate with these increases in costs.
Our revenues and volume trends are dependent on many factors, including physicians’ clinical decisions and availability, payer programs shifting to a more outpatient-based environment, whether or not certain services…
•
For example, as discussed elsewhere herein:
to implement, additional costly, technical and organizational measures designed to protect the privacy and security of each of our patient’s health and related financial information, and other personal information.
specifically ruling on the constitutionality of the Legislation.
The economies in the communities in which our hospitals operate are often dependent on a small number of large employers.
Typically, physicians are responsible for making hospital admissions decisions and for directing the course of patient treatment.
Texas.
At December 31, 2025, 21.3 million shares of Class B Common Stock were reserved for issuance upon conversion of shares of Class A, C and D Common Stock outstanding, for issuance upon exercise of options to purchase Cl…
Our $700 million, 1.65% senior notes ("2026 Notes") mature on September 1, 2026.
As inflationary pressures increase our operating costs, we may be unable to pass on the increased costs associated with providing healthcare services to our patients.
tariffs or trade barriers by the U.S., the European Union, Mexico, Canada, China or other countries, we can provide no assurance that any strategies we implement to mitigate the impact of such tariffs or other trade a…
estimate.
UHS Delaware, and the other defendants are evaluating all legal options and intend to challenge this verdict in post-judgment trial court proceedings and on appeal.
UHS Delaware is also a defendant in a lawsuit filed in Washoe County, Nevada, along with Pinnacle Management Group NV, LLC ("Pinnacle Medical Group", in which a subsidiary of the Company holds a 50% interest) and seve…
a Medicare self-referral disclosure protocol, which is intended to allow providers to self-disclose actual or potential violations of the Stark law.
including individual items and services and service packages, that could be provided by a hospital to a patient.
1115 waiver policy emphasized work requirements, eligibility restrictions on Medicaid, and capped funding.
There is a trend among private payers toward value-based purchasing of healthcare services, as well.
In addition, in some markets such as California, there are requirements to maintain specified nurse-staffing levels which could adversely affect our results of operations by increasing our salaries, wages and benefits…
technological advances in the health care industry, patients may seek treatment from other providers and/or physicians may refer their patients to alternate sources, which could adversely affect our results of operati…
In connection with the operations at our George Washington University Hospital and Cedar Hill Regional Medical Center located in Washington, D.
We derive a significant portion of our revenue from third-party payers, including the Medicare and Medicaid programs.
Universal Health Services SEC Filings
Latest annual and quarterly reports, current reports, proxy statements and ownership filings.
| Form | Filed | Description | Document |
|---|---|---|---|
| Current report (8-K) | 2026-10-27 | Quarterly results | View document |
| Ownership change (13D/13G) | 2026-10-19 | Large shareholder report (5% or more) | View document |
| Ownership change (13D/13G) | 2026-10-08 | Large shareholder report (5% or more) | View document |
| Current report (8-K) | 2026-08-21 | Material agreement, New debt | View document |
| Current report (8-K) | 2026-08-17 | New debt, Other news | View document |
Universal Health Services financial metrics by year
Universal Health Services in the S&P 500 rankings
- #29 by diluted earnings per share as of FY2025
S&P 500 is a trademark of S&P Dow Jones Indices LLC. StockYears is not affiliated with or endorsed by S&P Dow Jones Indices.
Compare Universal Health Services with similar companies
- UHS vs HCA HCA Healthcare